![James Veltmeyer](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
James Veltmeyer
Chief Tech/Sci/R&D Officer at THERAPEUTIC SOLUTIONS INTERNATIONAL, INC.
Net worth: 37 000 $ as of 31/05/2024
Profile
James Veltmeyer is currently the Chairman-Family Medicine at Sharp Grossmont Hospital since 2009.
He is also the Chief Medical Officer at Therapeutic Solutions International, Inc. since 2018.
Additionally, he is a Member at San Diego Critical Care Medical Group, Inc. Previously, Dr. Veltmeyer worked as an Associate at LXN Corp from 1997 to 2000.
In terms of education, Dr. Veltmeyer completed his undergraduate studies at the University of California San Diego and obtained a doctorate degree from Ross University School of Medicine.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
31/12/2023 | 37,000,000 ( 0.87% ) | 37 000 $ | 31/05/2024 |
James Veltmeyer active positions
Companies | Position | Start |
---|---|---|
THERAPEUTIC SOLUTIONS INTERNATIONAL, INC. | Chief Tech/Sci/R&D Officer | 18/06/2018 |
San Diego Critical Care Medical Group, Inc.
![]() San Diego Critical Care Medical Group, Inc. Medical/Nursing ServicesHealth Services San Diego Critical Care Medical Group, Inc. is an American company that operates as medical experts providing hospitalist care services. The private company is based in La Mesa. | Corporate Officer/Principal | - |
Sharp Grossmont Hospital
![]() Sharp Grossmont Hospital Hospital/Nursing ManagementHealth Services Sharp Grossmont Hospital operates hospitals. The private company is based in La Mesa. | Corporate Officer/Principal | 01/07/2009 |
Former positions of James Veltmeyer
Companies | Position | End |
---|---|---|
LXN Corp
![]() LXN Corp Pharmaceuticals: MajorHealth Technology Part of Johnson & Johnson, LXN Corp is a company that develops and commercializes fructosamine monitoring technology for diabetes. The company is based in San Diego, CA. The company was founded by John F. Burd. LXN was acquired by Inverness Medical Technology, Inc. on March 29, 2001 for $18.48 million. | Corporate Officer/Principal | 01/03/2000 |
Training of James Veltmeyer
University of California San Diego | Undergraduate Degree |
Ross University School of Medicine | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
THERAPEUTIC SOLUTIONS INTERNATIONAL, INC. | Health Technology |
Private companies | 3 |
---|---|
San Diego Critical Care Medical Group, Inc.
![]() San Diego Critical Care Medical Group, Inc. Medical/Nursing ServicesHealth Services San Diego Critical Care Medical Group, Inc. is an American company that operates as medical experts providing hospitalist care services. The private company is based in La Mesa. | Health Services |
Sharp Grossmont Hospital
![]() Sharp Grossmont Hospital Hospital/Nursing ManagementHealth Services Sharp Grossmont Hospital operates hospitals. The private company is based in La Mesa. | Health Services |
LXN Corp
![]() LXN Corp Pharmaceuticals: MajorHealth Technology Part of Johnson & Johnson, LXN Corp is a company that develops and commercializes fructosamine monitoring technology for diabetes. The company is based in San Diego, CA. The company was founded by John F. Burd. LXN was acquired by Inverness Medical Technology, Inc. on March 29, 2001 for $18.48 million. | Health Technology |
- Stock Market
- Insiders
- James Veltmeyer